Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 3Recruiting 3Not yet recruiting 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Malnutrition 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Body Weight Changes 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × OTHER × Nutrition Therapy × Clear all
NCT00769652 2023-10-03

Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer

Rutgers, The State University of New Jersey

Phase NA Terminated
8 enrolled 6 charts
GastrointestinalGenitourinaryThoracic

Body Weight Changes, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Malnutrition, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡